Stay updated on ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial
Sign up to get notified when there's something new on the ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial page.

Latest updates to the ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial page
- Check7 days agoChange DetectedA new revision entry v3.3.2 has been added to the page's revision history, replacing the previous v3.3.1 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check14 days agoChange DetectedFooter shows a new Revision from v3.2.0 to v3.3.1. No study details or page content appear to be affected.SummaryDifference0.1%

- Check21 days agoChange DetectedThe government funding banner at the top of the page was removed, an administrative update that does not affect trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check36 days agoChange DetectedThere are no substantive changes to the study record content; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedSummary of changes: added a government-status notice and updated version to v3.2.0; removed reference to v3.1.0.SummaryDifference11%

- Check72 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new version is available.SummaryDifference0.3%

Stay in the know with updates to ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial page.